Please login to the form below
Merck KGaA
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.
Merck takes evobrutinib for MS into phase 3, on mixed data
Merck KGaA is putting its BTK inhibitor evobrutinib to the test in two phase 3 multiple sclerosis (MS) trials, the first drug in the class to reach that stage for the ... Merck says however that the liver enzyme increases reversed after treatment was
Novartis’ lung cancer drug wins FDA Breakthrough Therapy Designation
However, rival Merck KGaA has its own candidate, tepotinib, which is also being investigated in this rare form of lung cancer. ... Merck’s tepotinib also picked up fast-track status from the US regulator earlier this year, which means the race to
MSD’s Keytruda catches up in kidney cancer
president, clinical research, Merck Research Laboratories. ... added. The kidney cancer market is now becoming increasingly competitive, with Keytruda and Opdivo also facing competition from Pfizer/Merck KGaA’s Bavencio (avelumab), which was approved
GSK hires Merck KGaA exec to lead US pharma business
Maya Martinez-Davis. Martinez-Davis currently serves as president of biopharma Latin America at Merck KGaA but her two previous positions were focused squarely on oncology. ... Over the past year, GSK has doubled the size of its oncology pipeline, in
Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease
The new data adds to a building body of evidence behind imeglimin after around a decade of development at Poxel, a spin-out of Merck KGaA formed specifically to advance the
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...
Latest intelligence
- Article: Like, Like, Like: Harnessing the power of social media insights
- ...
- Its Know Your Numbers week
- Do you know yours?...
- What is changing in mental health and dementia care?
- Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...
Quick links
Infographics
